3Mohammed RA, Green A, El-Shikh S, et al. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with anglo- and lymphangiogenesis. Br J Cancer, 2007, 96:1092-1100.
4Juttner S, Wissmann C, Jtins T, et al. Vascular endothelial growth factor- D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol, 2006, 24:228- 240.
5Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol, 2005, 18 : 143-152.
6Hirakawa S, Kodama S, Kunstfeld R, et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med, 2005, 201:1089-1099.
7Fondevila C, Metges JP, Fuster J, et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer, 2004, 90:206- 215.
8Aoyagi K, Kouhuji K, Yano S, et al. VEGF significance in peritoneal recurrence from gastric cancer. Gastric Cancer, 2005, 8:155-163.
9Bjorndahl MA, Cao R, Burton JB, et al. Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res, 2005, 65:9261-9268.
10Kondo K, Kaneko T, Baba M, et al. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull, 2007, 30:633-637.
